Loading...

Immutep Limited

IMMP•NASDAQ
Healthcare
Biotechnology
$0.54
$0.23(72.81%)
U.S. Market opens in 16h 29m

Immutep Limited (IMMP) Stock Overview

Explore Immutep Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap80.2M
P/E Ratio-0.78
EPS (TTM)$-0.40
ROE-0.69%
Fundamental Analysis

AI Price Forecasts

1 Month$2.39
3 Months$3.44
1 Year Target$2.42

IMMP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Immutep Limited (IMMP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 13.06, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $2.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.78 and a market capitalization of 80.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
72.81%
5-Day Change
69.21%
1-Month Change
12.26%
3-Month Change
-82.05%
6-Month Change
-74.34%
Year-to-Date (YTD) Change
-80.98%
1-Year Change
-63.97%
3-Year Change
-65.79%
5-Year Change
-83.86%
All-Time (Max) Change
-99.59%

Contact Information

https://www.immutep.com
61 2 8315 7003
Australia Square, Sydney, NSW, 2000

Company Facts

41 Employees
IPO DateApr 19, 2012
CountryAU
Actively Trading

Frequently Asked Questions